CISA ADP Vulnrichment (CVE-2025-53867) | HOL Guard CVE

Critical · CVSS 9.8CVE-2025-53867

CISA ADP Vulnrichment

Answer in brief

CVE-2025-53867 records a Critical severity (CVSS 9.8) vulnerability in CISA ADP Vulnrichment. The current sources do not mark it as known exploited. The current feed maps n/a/n/a (generic). Check affected ranges and fixed versions before updating.

Analysis pending evidence review

HOL Guard separates source facts from reviewed analysis. See the methodology.

Published Jul 17, 2025Updated Jul 5, 2026Source checked Aug 5, 2026First seen by HOL Jul 5, 2026Material review Jul 5, 2026

Upstream Advisory

Key facts

Risk: Critical · CVSS 9.8
Exploitation: Not marked as known exploited
Affected software: 1 mapped package or product
Fix availability: Not reported

Why this deserves its current priority

CVSS is 9.8. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.

Analysis status

Analysis pending evidence review

Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.

Affected scope and exposure questions

The current feed maps n/a/n/a (generic). Check affected ranges and fixed versions before updating.

Mapped affected packages and fixed versions
Package	Affected range	Fixed version
n/a/n/ageneric	n/a	Not reported

Recommended response

Check inventory. Check lockfiles and deployed manifests for n/a/n/a.
Review the reported fix. Monitor this advisory for an available fix and review any installs of the affected package.

Evidence timeline and material changes

Published upstream
Jul 17, 2025
Evidence: source:cvelist:source_dates:source-dates:record
Source modified
Jul 5, 2026
Evidence: source:cvelist:source_dates:source-dates:record
First seen by HOL
Jul 5, 2026

Sources and claim methodology

Upstream source description

Island Lake WebBatch before 2025C allows Remote Code Execution via a crafted URL.

Quoted source text, attributed separately from HOL analysis.

Back to active CVEs

Critical · CVSS 9.8CVE-2025-53867

CISA ADP Vulnrichment

Answer in brief

Analysis pending evidence review

HOL Guard separates source facts from reviewed analysis. See the methodology.

Published Jul 17, 2025Updated Jul 5, 2026Source checked Aug 5, 2026First seen by HOL Jul 5, 2026Material review Jul 5, 2026

Upstream Advisory

Key facts

Risk: Critical · CVSS 9.8
Exploitation: Not marked as known exploited
Affected software: 1 mapped package or product
Fix availability: Not reported

Why this deserves its current priority

CVSS is 9.8. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.

Analysis status

Analysis pending evidence review

Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.

Affected scope and exposure questions

The current feed maps n/a/n/a (generic). Check affected ranges and fixed versions before updating.

Mapped affected packages and fixed versions
Package	Affected range	Fixed version
n/a/n/ageneric	n/a	Not reported

Recommended response

Check inventory. Check lockfiles and deployed manifests for n/a/n/a.
Review the reported fix. Monitor this advisory for an available fix and review any installs of the affected package.

Evidence timeline and material changes

Published upstream
Jul 17, 2025
Evidence: source:cvelist:source_dates:source-dates:record
Source modified
Jul 5, 2026
Evidence: source:cvelist:source_dates:source-dates:record
First seen by HOL
Jul 5, 2026

Sources and claim methodology

Upstream source description

Island Lake WebBatch before 2025C allows Remote Code Execution via a crafted URL.

Quoted source text, attributed separately from HOL analysis.

CISA ADP Vulnrichment

Key facts

Why this deserves its current priority

Affected scope and exposure questions

Recommended response

Evidence timeline and material changes

Sources and claim methodology

Related CVEs

CISA ADP Vulnrichment

Key facts

Why this deserves its current priority

Affected scope and exposure questions

Recommended response

Evidence timeline and material changes

Sources and claim methodology

Related CVEs